Incidence of Major Bleeding in Patients with Pulmonary Thromboembolism Treated with Fixed Dose Alteplase 100 mg

BACKGROUND: Acute pulmonary thromboembolism (PTE) is a critical cardiopulmonary condition associated with high mortality and morbidity. In massive PTE, recently referred to as high risk PTE, the routine protocol for thrombolysis with recombinant tissue plasminogen activator (alteplase) is 100 mg ove...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Korean Med Sci
Hlavní autoři: Bae, Dae-Hwan, Lee, Won Jae, Shin, Yoon Mi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Academy of Medical Sciences 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7445310/
https://ncbi.nlm.nih.gov/pubmed/32830464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2020.35.e267
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky